Drug Policy and the Public Good by Robin Room, Jonathan P. Caulkins, Peter Reuter, David R. Foxcroft, Griffith Edwards, Jurgen T. Rehm, Keith Humphreys, Thomas F. Babor, Isidore S. Obot, Benedikt Fisher (Paperback, 2009)
Drug use represents a significant burden to public health through disease, disability and social problems, and policy makers are becoming increasingly interested in how to develop evidence-based drug policy. It is therefore crucial to strengthen the links between addiction science and drug policy.Drug Policy and the Public Good is collaboratively written by an international group of career scientists to provide an analytical basis on which to build relevant global drug policies, and to inform policy makers who have direct responsibility for public health and social welfare. Drug Policy and the Public Good presents, in a comprehensive, practical, and readily accessible form, the accumulated scientific kwledge on illicit drugs that has direct relevance to the development of drug policy on local, national, and international levels. The authors describe the conceptual basis for a rational drug policy and present new epidemiological data on the global dimensions of drug misuse. The core of the book is a critical review of the cumulative scientific evidence in five general areas of drug policy: primary prevention programs in schools and other settings; supply reduction approaches, including drug interdiction and legal enforcement; treatment interventions and harm reduction approaches; criminal sanctions and decriminalization; and control of the legal market through prescription drug regimes. The final chapters discuss the current state of drug policy in different parts of the world, and describe the need for a new approach to drug policy that is evidence-based, realistic, and co-ordinated. The authors describe the conceptual basis for a rational drug policy and present new epidemiological data on the global dimensions of drug misuse. The core of the book is a critical review of the cumulative scientific evidence in five general areas of drug policy: primary prevention programs in schools and other settings; supply reduction approaches, including drug interdiction and legal enforcement; treatment interventions and harm reduction approaches; criminal sanctions and decriminalization; and control of the legal market through prescription drug regimes. The final chapters discuss the current state of drug policy in different parts of the world, and describe the need for a new approach to drug policy that is evidence-based, realistic, and co-ordinated. By locating drug policy primarily within the realm of public health, this book draws attention to the growing tendency of governments, both national and local, to consider illegal psychoactive substances as a major determinant of ill health, and to organize societal responses accordingly. It will appeal to those involved in both addiction science and drug policy, as well as those in the wider fields of public health, health policy, epidemiology, primary prevention, and treatment services. A companion volume published by Oxford University Press, Alcohol: ordinary commodity - research and public policy, is also available.
Thomas Babor is a Professor and Chairman in the Department of Community Medicine and Health Care, University of Connecticut School of Medicine. He holds the University's Physicians Health Service endowed chair in Public Health and Community Medicine. Dr. Babor received his doctoral degree in social psychology from the University of Arizona in 1971. He spent several years in postdoctoral research training in social psychiatry at Harvard Medical School, and subsequently served as head of social science research at McLean Hospital's Alcohol and Drug Abuse Research Center in Belmont, Massachusetts. Since 1997 he has been chairman of the Department of Community Medicine and Health Care at the University of Connecticut School of Medicine. He is Associate Editor-in-Chief as well as Regional Editor of the international journal, Addiction. His research interests include screening, diagnosis, early intervention, and treatment evaluation, as well as cultural and policy issues to alcohol and drug problems. Jonathan P. Caulkins is Professor of Operations Research and Public Policy at Carnegie Mellon University's Qatar campus in Doha and its Heinz School of Public Policy. He currently holds a Robert Wood Johnson Foundation Health Investigator Award in Health Policy Research. Dr. Caulkins specializes in mathematical modeling and systems analysis with a particular focus on social policy systems pertaining to drugs, crime, terror, violence, and prevention. Other interests include software quality, optimal control, airline operations, and personnel performance evaluation. At RAND he has been a consultant, visiting scientist, co-director of RAND's Drug Policy Research Center (1994 - 1996), and founding director of RAND's Pittsburgh office (1999-2001). Dr. Caulkins received a B.S., and M.S. in Systems Science from Washington University, an S.M. in Electrical Engineering and Computer Science and Ph.D., in Operations Research both from M.I.T. Griffith Edwards qualified in medicine and subsequently specialised in the study and treatment of substance misuse. Holder of Jellinek award (International Alcohol Research prize) and Nathan Eddy Award (International Drugs Research prize). Distinguished Fellow of the Society for the Study of Addiction. Fellow of the Academy of Medical Sciences. David Foxcroft is a Chartered Psychologist specializing in Prevention Science. His major research interest is in the prevention of drug and alcohol misuse, especially in young people. David graduated from Hull University in 1990 with a BSc (Hons) in Psychology, and in 1993 with a PhD in Health Psychology. He subsequently held posts at the Universities of Portsmouth and Southampton before coming to Oxford Brookes in 1999. Keith Humphreys, Professor of Psychiatry at Stanford University School of Medicine, received his doctorate in clinical/community psychology from the University of Illinois at Urbana, and his practice license from the State of California Board of Psychology. He currently directs the Veterans Affairs Program Evaluation and Resource Center, which studies treatments and self-help programs for substance abuse and psychiatric disorders. In addition to his scientific projects, he is actively involved in teaching addiction treatment methods to medical students, psychiatric residents, and clinical psychology interns. Professor Humphreys has published more than one hundred scientific articles, has received national and international awards for his work, and has been a consultant to science and human service agencies in the United States, Spain, Bulgaria, Iraq, Ireland, Canada, and South Africa. Isidore Obot is Professor of Psychology at the University of Uyo, Nigeria, and Director, at the Centre for Research and Information on Substance Abuse (CRISA). Before his appointment in Uyo in 2008, he was Professor and Chair in the Department of Behavioral Health Sciences at Morgan State University School of Public Health, worked as a scientist
Benedikt Fisher, David R. Foxcroft, Griffith Edwards, Isidore S. Obot, Jonathan P. Caulkins, Jurgen T. Rehm, Keith Humphreys, Peter Reuter, Robin Room, Thomas F. Babor